The impact of prevention on reducing the burden of cardiovascular disease

Circulation

Volumn 118, Issue 5, 2008, Pages 576-585

  Kahn, Richard ^a   Robertson, Rose Marie ^b   Smith, Robert ^c   Eddy, David ^d  

^a AMERICAN DIABETES ASSOCIATION   (United States)

^b AMERICAN HEART ASSOCIATION   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d Arhimedes Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEALTH CARE COST; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MORBIDITY; MORTALITY; OBESITY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SIMULATION; SMOKING CESSATION; STROKE; UNITED STATES; WEIGHT REDUCTION; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MORBIDITY; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 49649102993     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.190186     Document Type: Article

References (44)

1. Rosamond W, Flegal K. Furie K, Go A, Greenland K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinerger J, Thom T, Wilson M, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-e146.
2. Hogan P, Dall T, Nikolov P, American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care. 2003;26:917-932.
3. Ries L, Harkins D, Krapcho M, Mariotto A, Miller B, Feuer E. SEER Cancer Statistics Review, 1975-2003. Bethesda, Md: National Cancer Institute; 2006.
4. Centers for Disease Control and Prevention. Addressing the Nation's Leading Killers. 2006. Atlanta, Ga: Centers for Disease Control; 2006.
5. Centers for Disease Control and Prevention. Diabetes: Disabling, Deadly, and an the Rise. 2006 Fact Sheet. Atlanta, Ga: Centers for Disease Control; 2006.
6. Yusuf S. Two decades of progress in preventing vascular disease. Lancet. 2002;360:2-3.
7. American Diabetes Association. Prevention or delay of type 2 diabetes (Position Statement). Diabetes Care. 2004;27(Suppl. 1):S47-S54.
8. Eyre H, Kahn R, Robertson RM, Clark NG, Doyle C, Hong Y, Gansler T, Glynn T, Smith RA, Taubert K, Thun MJ. Preventing cancer, cardiovascular disease and diabetes: a common agenda for the American Cancer Society, American Diabetes Association, and American Heart Association. Circulation. 2004;109:3244-3255.
9. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16-22.
10. Chiuve SE. McCullough ML, Sacks FM, Rimm EB. Healthy lifestyle factors in the primary prevention of coronary heart disease among men. Circulation. 2006;114:160-167.
11. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
12. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346: 393-403.
13. Vollset SE, Tverdal A, Gjessing HK. Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med. 2006;144:381-389.
14. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW. Major risk factors as antecedents of fatal and nonfalal coronary heart disease events. JAMA. 2003;290:891-897.
15. Pignone M, Earnshaw S, Tice JA, Pletcher MJ. Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Ann Intern Med. 2006;144:326-336.
16. Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002:136: 161-172.
17. Pygove MP, Phillips CT, Atkins D, Teutch SM, Mulrow CD, Lohr KN. Screening and treating adults for lipid disorders. Am J Prev Med. 2001; 20:77-89.
18. Yamell KSH, Pollack KI, Ostbye T, Krouse KM, Michener TL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93: 635-641.
19. Smith RA, Wender RC. Cancer screening and the periodic health examination. Cancer. 2004;100:1553-1557.
20. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Rother J, Wilson PW, REACH Registry Investigators. International prevalence, recognition, and treatment for cardiovascular risk factor in outpatients with atherothrombosis. JAMA. 2006;295: 180-189.
21. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, Narayan KM. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006;144:465-474.
22. Schlessinger L, Eddy DM. Archimedes, a new model for simulating health care systems: the mathematical formulation. J Biomed Inform. 2002;35:37-50.
23. Eddy DM, Schlessinger L. Archimedes: a trial-validated model of diabetes. Diabetes Care. 2003;26:3093-3101.
24. Eddy DM, Schlessinger L. Validation of the Archimedes diabetes model. Diabetes Care. 2003;26:3102-3110.
25. Eddy DM, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med. 2005;143:251-264.
26. Schlessinger L, Eddy DM. Equations for the Archimedes model (technical report online), 2007. Available from http://archimedesmodel. com. Accessed February 8, 2008.
27. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
28. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
29. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2007;30(suppl):S4-S41.
30. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363-2372.
31. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases: American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-391.
32. Gold MR, Siegal JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
33. American Diabetes Association Consensus Panel. Guidelines for computer modeling of diabetes and its complications. Diabetes Care. 2004;27:2262-2265.
34. National Center for Health Statistics. National Health and Nutrition Examination Study (NHANES) 4 (Web site). Available from http://www.cdc.gov/nchs/ nhanes.htm. Accessed February 8, 2008.
35. The Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care. 2003;26:1-12.
36. Ajani UA, Ford ES, Greenland KJ, Giles WH, Mokdad AH. Aspirin use among U.S. adults: behavioral risk factor surveillance system. Am J Prev Med. 2006;30:74-77.
37. National Committee for Quality Assurance (NCQA). Personal communication. Unpublished data derived from the 90th performance level for health plans in the NCQA system or the average performance level achieved by physicians successfully achieving ADA/NCQA Physician Recognition, 2006.
38. Kerr EA, Gerzoff RB, Krein SL, Selby JV, Piette JD, Curb JD, Herman WH, Marrero DG, Narayan KM, Safford MM, Thompson T, Mangione CM. Diabetes care quality in the Veterans Affairs health care system and commercial managed care: the TRIAD study. Ann Intern Med. 2004;141: 272-281.
39. Imperatore G, Cadwell BL, Geiss L, Saaddine JB, Williams DE, Ford ES, Thompson TJ, Narayan KM, Gregg EW. Thirty year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. Am J Epidemiol. 2004; 160:531-539.
40. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.
41. Wing RR, Tate DF, Gorin AA, Raynor HA, Fava JL. A self-regulation program for maintenance of weight loss. N Engl J Med. 2006;355: 1563-1571.
42. Gardner C, Kiazand A, Alhassan S, Soowon K, Stafford R, Balise R, Kraemer H, King A. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women. JAMA. 2007;297:969-977.
43. Sullivan PW, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26: 410-420.
44. Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med. 2006;31: 52-61.